NYSE$BARK
The Original Bark Co · Q2 2026 earnings
Q2 2026 earnings · · Before market open · Investor relations
Briefing
BARK reported Q2 2026, revenue of $107M, a net loss of $10.7M.
For Q2 2026, BARK reported revenue of $107M, a net loss of $10.7M. Management discusses operating trends, liquidity, and strategic priorities as disclosed in the quarterly filing.
- Revenue $107M.
- Net loss $10.7M.
- BARK updated clinical, capital, or portfolio priorities in the filing.
Headline financials
Revenue & EPS history
Bark · Revenue · Quarterly
$107M
Revenue by segment
Bark · $123M total across 2 segments · Q2 2024
- Direct to Consumer$104M—84.8%
- Commerce$18.7M—15.2%
Forward guidance
Management discusses BARK's outlook, capital deployment, and key risks as disclosed in the earnings materials and periodic report.
Tailwinds
- BARK cited progress on strategic priorities in the quarterly filing.
- Liquidity and balance sheet support continued operations and investment.
Headwinds
- GAAP profitability remained under pressure in the reported quarter.
- Macro, competitive, and regulatory factors may affect near-term results.
- R&D, credit, or project timing can create quarter-to-quarter volatility.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2026
-3.0%
Avg return
Earnings day
-4.2%
Avg return
5 days after
-7.1%
Avg return
30 days after
48%
12 / 25 earnings
Positive
+22.3%
Q1 2023
Best reaction
-24.6%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +2.2% | -13.4% | — | |
| Q3 2026 | -2.6% | -5.7% | -7.6% | |
| Q2 2026 | +0.0% | -6.3% | -16.7% | |
| Q1 2026 | -6.3% | -2.9% | +2.6% | |
| Q4 2025 | +1.6% | -2.4% | -34.6% | |
| Q3 2025 | -6.6% | +0.0% | -20.9% | |
| Q2 2025 | -6.0% | +1.3% | +53.6% | |
| Q1 2025 | +11.7% | +11.7% | +18.2% | |
| Q4 2024 | +0.8% | +2.3% | +30.0% | |
| Q3 2024 | +13.4% | +26.5% | +51.6% | |
| Q2 2024 | -22.3% | -25.2% | -22.6% | |
| Q1 2024 | -9.5% | -12.4% | +12.4% | |
| Q4 2023 | +9.6% | +5.8% | +27.9% | |
| Q3 2023 | -24.6% | -31.5% | -41.9% | |
| Q2 2023 | -5.6% | -4.5% | -12.9% | |
| Q1 2023 | +22.3% | +36.0% | +22.3% | |
| Q4 2020 | -16.2% | -28.5% | -50.8% | |
| Q4 2022 | -16.2% | -28.5% | -50.8% | |
| Q3 2022 | -19.5% | -22.1% | -33.3% | |
| Q2 2022 | -13.4% | -11.8% | -37.7% | |
| Q1 2021 | +0.8% | -2.1% | -7.2% | |
| Q4 2021 | +0.8% | -2.1% | -7.2% | |
| Q1 2022 | +5.9% | +2.3% | -6.3% | |
| Q2 2021 | +3.3% | +11.5% | -13.9% | |
| Q3 2021 | +1.0% | -1.8% | -25.6% | |
| Q2 2020 | — | — | — | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro